Selling to a DSO makes strong financial sense for practices generating $1.5M or more in revenue with healthy EBITDA. DSOs routinely pay multiples that individual buyers can’t match. But higher valuations aren’t the whole picture. Whether a DSO partnership is right depends on your timeline, your goals after the sale, and how much you’re willing to adapt to a corporate operating environment.
What DSOs Are Looking For – and Why They Pay More
DSOs – Dental Service Organizations – are managed service organizations that own or affiliate with dental practices and handle the non-clinical side of the business: HR, billing, marketing, purchasing, and compliance.
Because DSOs operate at scale, they extract more value from a practice than an individual buyer can. They pay a multiple on EBITDA (earnings before interest, taxes, depreciation, and amortization) – the metric that reflects the practice’s true earnings power after owner-related expenses. Individual buyers typically pay on revenue or a flat appraised value. The difference in multiple can be material.
What DSOs look for: revenue of $1.5M or above, EBITDA of $250K or more, consistent growth trajectory, strong patient retention and hygiene production, and favorable geography relative to the buyer’s existing platform.
When a DSO Partnership Makes Sense
Financial performance thresholds
If your practice meets or exceeds those revenue and EBITDA benchmarks, a DSO sale is worth understanding. Corporate buyers in the dental space have been paying 4-6x EBITDA for well-positioned practices – a range that individual buyers rarely reach.
The headline multiple doesn’t tell the whole story. How the deal is structured – how much is cash at close versus rolling equity versus earn-outs – determines what you actually receive.
“I wanted to give the office to a good person. It’s like your baby,” said Dr. Emily Lee.
Selling to a DSO that shares your values and has a track record of treating acquired practices well matters beyond the financial terms.
Rolling equity upside
Many DSO deals include a rolling equity component: you retain a percentage stake in the buyer platform and benefit from future appreciation when the platform eventually exits. This is a real wealth-building opportunity when the buyer is well-capitalized and growing.
Rolling equity has produced significant returns for some PTG clients. For others, the platform hasn’t yet reached an exit event. Evaluate it as a long-term investment – not as part of your guaranteed close proceeds.
Operational Relief – What It Actually Looks Like
One of the most cited reasons dentists sell to DSOs is relief from the administrative side of running a practice. That relief is real. After closing, the DSO’s team takes over HR and staffing decisions, insurance and compliance management, technology and software, marketing, and day-to-day billing.
“This is our first time ever in 15 years…no calls no emails,” said Dr. Robert Hendricks.
The tradeoff is also real. Clinical autonomy varies by DSO. Some platforms take a hands-off approach to treatment decisions. Others are more directive. Asking to speak with prior selling doctors during due diligence is a reasonable request – any serious buyer will accommodate it.
When a DSO Isn’t the Right Fit
Most content on DSO sales is written by people with a financial interest in the outcome. PTG works exclusively for sellers, which means we’re in a position to tell you when it’s the wrong call.
If clinical independence is non-negotiable. DSO structures involve standardized processes, shared decision-making, and protocols set by the platform. If your clinical approach depends on full autonomy, evaluate that honestly before committing.
If you have 6 or more years of practice left and no burnout. For doctors who want to continue building value, staying independent may produce better long-term financial results than selling now and receiving associate compensation post-close.
If the post-sale compensation structure doesn’t work. Do the math on what you’ll receive as an employed clinician after close. If the combined sale proceeds plus projected employment income don’t meet your financial goals, explore other structures or timing before signing.
How to Evaluate a DSO as a Partner
Not all DSOs are the same. The PE backer behind the platform, its integration track record, and its culture will matter to your daily experience for 2-3 years post-close.
Questions worth getting answered: Who is the PE sponsor, and when was the last fund vintage? How do prior selling doctors describe the integration experience? What specifically changes in clinical operations, and what doesn’t? What does post-sale employment compensation look like, and what are the performance conditions?
PTG’s transaction history spans a large cross-section of DSO buyers. We know which platforms have strong integration reputations and which have a track record of friction. That knowledge is part of what a sell-side advisor brings to a transaction. What actually happens after closing is also worth understanding before you sign.
FAQ
How much will a DSO pay for my dental practice?
It depends primarily on EBITDA and revenue. Corporate buyers in dental typically pay 4-6x EBITDA for practices that meet their acquisition criteria. A $500K EBITDA practice in an active market could clear $2-3M from a DSO buyer. Individual buyers typically pay less. Our dental practice valuation calculator can give you a rough estimate based on your numbers.
What is rolling equity in a DSO deal?
Rolling equity is a portion of your practice’s sale value that stays invested in the buying platform rather than paid at close. If the platform grows and eventually sells to a larger buyer, your equity stake appreciates. It’s a wealth-building opportunity, but it depends on the platform’s growth and exit timeline. How rolling equity works in practice is worth understanding before any negotiation.
Will I still be able to practice dentistry after selling to a DSO?
In most cases, yes. DSO deals typically include a 2-3 year employment agreement during which you continue practicing clinically. What changes is the administrative side – the DSO takes over business operations. How much clinical autonomy you retain varies by platform and is a real negotiating point.
How long does a DSO acquisition take from offer to close?
From signed LOI to close typically takes 60-120 days, depending on due diligence complexity. The integration period after closing is a separate phase that usually takes 6-12 months to complete fully.
What’s the difference between a DSO and a private buyer?
A private buyer purchases the practice and takes over all clinical and business operations. A DSO affiliates with the practice – you typically stay on as an employed clinician while the DSO takes over management. The financial terms differ significantly: DSOs pay higher multiples but the structure is more complex.
Start With Your Numbers
Understanding your EBITDA and market value is the foundation of any DSO evaluation. Our dental practice valuation calculator gives you a starting point. When you’re ready to talk through what a competitive sale process could look like, our team is available.
